Visual hallucinations: Differential diagnosis and treatment

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 1, 2009, Pages 26-32

  Teeple, Ryan C ^a   Caplan, Jason P ^b   Stern, Theodore A ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; QUETIAPINE; TRIPTAN DERIVATIVE;

ALZHEIMER DISEASE; ANTON SYNDROME; ARTICLE; BRAIN ATROPHY; BRAIN SURGERY; BRAIN TUMOR; CHARLES BONNET SYNDROME; CREUTZFELDT JAKOB DISEASE; DELIRIUM; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAM; HALLUCINOSIS; HUMAN; INBORN ERROR OF METABOLISM; MIGRAINE; NEUROIMAGING; NOCICEPTIVE STIMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PEDUNCULAR HALLUCINOSIS; PERCEPTION DISORDER; PSYCHOBIOLOGY; PSYCHODYNAMICS; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; RADIOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEIZURE; SLEEP DISORDER; VISUAL CORTEX; VISUAL HALLUCINATION;

EID: 78650800213     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08r00673     Document Type: Article

References (55)

1. Asaad G, Shapiro B. Hallucinations: theoretical and clinical overview. Am J Psychiatry 1986;143:1088-1097
2. Manford M, Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain 1998;121:1819-1840
3. Price J, Whitlock FA, Hall RT. The psychiatry of vertebrobasilar insufficiency with the report of a case. Psychiatr Clin (Basel) 1983;16:26-44
4. Menon GJ, Rahman I, Menon SJ, et al. Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Ophthalmol 2003;48:58-72
5. Burke W. The neural basis of the Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002;73:535-541
6. Cogan DG. Visual hallucinations as release phenomena. Albrecht Vo n Graefes Arch Klin Exp Ophthalmol 1973 Aug;188(2):139-150
7. Merabet LB, Maguire D, Warde A, et al. Visual hallucinations during prolonged blindfolding in sighted subjects. J Neuroophthalmol 2004 Jun;24(2):109-113
8. First MB, Tasman A. Schizophrenia and other psychotic disorders. In: DSM-IV-TR Mental Disorders: Diagnosis, Etiology, and Treatment. San Francisco, Calif: Wiley; 2004:640
9. Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia. Acta Psychiatr Scand 1990;82:26-29
10. Small IJ, Small JG, Andersen HJM. Clinical characteristics of hallucinations of schizophrenia. Dis Nerv Syst 1966;27:349-353
11. Goodwin DW, Alderson P, Rosenthal R. Clinical significance of hallucinations in psychiatric disorders: a study of 116 hallucinatory patients. Arch Gen Psychiatry 1971;24:76-80
12. Armstrong SC, Cozza KL, Watanabe KS. The misdiagnosis of delirium. Psychosomatics 1997;38(5):433-439
13. Swigart SE, Kishi Y, Thurber S, et al. Misdiagnosed delirium in patient referrals to a university-based hospital psychiatry department. Psychosomatics 2008;49:104-108
14. Webster R, Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics 2000;41:519-522
15. Gastfriend DR, Renner JA, Hackett T P. Alcoholic patients: acute and chronic. In: Stern TA, Fricchione GL, Cassem NH, et al, eds. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 5th ed. Philadelphia, Pa: Mosby; 2004:203-216
16. Mitchell J, Vierkant AD. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. J Psychol 1991;125:301-310
17. Ballard CG, O'Brien JT, Swann AG, et al. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001;62(1):46-49
18. Ala TA, Yang KH, Sung JH, et al. Hallucinations and signs of parkinson-ism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopatho-logical study. J Neurol Neurosurg Psychiatry 1997;62:16-21
19. Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 2006 Mar;129:729-735
20. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125:391-403
21. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idio-pathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005;4:605-610
22. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123: 733-745
23. Lippa CF, Duda JE, Grossman M, et al. DLB/PDD Working Group: DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007;68:812-819
24. Josephs KA, Whitwell JL, Boeve BF, et al. Visual hallucinations in posterior cortical atrophy. Arch Neurol 2006;63:1427-1432
25. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993;43:305-313
26. Rovner BW. The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 2006;17(3):275-277
27. Maeda K, Shirayama Y, Nukina S, et al. Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone [letter]. J Clin Psychiatry 2003;64(9):1131-1132
28. Coletti Moja M, Milano E, Gasverde S, et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci 2005;26: 168-170
29. Lang UE, Stogowski D, Schulze D, et al. Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007; 21:553-555
30. Critchley M. Modes of reaction to central blindness. In: The Divine Banquet of the Brain. New York, NY: Raven; 1979:156
31. Miller N. Walsh and Hoyt's Clinical Neuro-ophthalmology. Baltimore, Md: Williams and Wilkins; 1982:144
32. Aldrich MS, Alessi AG, Beck RW, et al. Cortical blindness: etiology, diagnosis and prognosis. Ann Neurol 1987;21:149-158
33. Goldenberg G, Müllbacker W, Nowak A. Imagery without perception: a case study of anosognosia for cortical blindness. Neuropsychologia 1995;33:1373-1382
34. Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation, and outcome in 42 patients treated between 1930 and 1991: surgery of occipital lobe epilepsy. Brain 1992 Dec;115:1655-1680
35. Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry 1999;66:536-540
36. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399
37. Devinsky O, Luciano D. Psychic phenomena in partial seizures. Semin Neurol 1991;11(2):100-109
38. Wieser HG. The phenomenology of limbic seizures. In: Wieser HG, Speckman E-J, Engel J, eds. The Epiletic Focus. London, England: John Libbey; 1987
39. Caplan JP, Epstein LA, Stern TA. Consultants' conflicts: a case discussion of differences and their resolution. Psychosomatics 2008;49(1):8-13
40. Waters WE, O'Connor PJ. Prevalence of migraine. J Neurol Neurosurg Psychiatry 1975;38:613-616
41. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346:257-270
42. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996;119:355-361
43. Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-4692
44. Catafau JS, Rubio F, Serra J P. Peduncular hallucinosis associated with posterior thalamic infarction. J Neurol 1992;239:89-90
45. Aldrich MS. Diagnostic aspects of narcolepsy. Neurology 1998 Feb; 50(2 supp 1):S2-S7
46. Ohayon MM, Priest RG, Caulet M, et al. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996;169: 459-467
47. Broughton RJ. Neurology and dreaming. Psychiatric J University of Ottawa 1982;7:101-110
48. Nichols DE. Hallucinogens. Pharmacol Ther 2004;101:131-181
49. Cushing H. Distortions of the visual fields in cases of brain tumor (6th paper): the field defects produced by temporal lobe lesions. Brain 1922;44:341-396
50. Horrax G, Putnam TJ. Distortions of the visual fields in cases of brain tumour: the field defects and hallucinations produced by tumours of the occipital lobe. Brain 1932;55:499-523
51. Sedes F, Baumann N, Turpin JC, et al. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 2007;30:631-641
52. Moellentine CK, Rummans TA. The varied neuropsychiatric presentations of Creutzfeldt-Jakob disease. Psychosomatics 1999;40:260-263
53. Brar HK, Vaddigiri V, Scicutella A. Of illusions, hallucinations and Creutzfeldt-Jakob disease (Heidenhain's variant). J Neuropsychiatry Clin Neurosci 2005;17:124-126
54. Furlan AJ, Henry CE, Sweeney PJ, et al. Focal EEG abnormalities in Heidenhain's variant of Jakob-Creutzfeldt disease. Arch Neurol 1981;38(5):312-314
55. Caplan JP. Diagnosis and treatment of agitation and delirium in the ICU patient. In: Irwin RS, Rippe JM. Irwin and Rippe's Intensive Care Medicine. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2007: 2287-2295